SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-072253
Filing Date
2023-06-16
Accepted
2023-06-16 16:20:29
Documents
13
Period of Report
2023-06-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2318884d1_8k.htm   iXBRL 8-K 34948
2 EXHIBIT 10.1 tm2318884d1_ex10-1.htm EX-10.1 1365350
  Complete submission text file 0001104659-23-072253.txt   1855495

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pahc-20230616.xsd EX-101.SCH 3021
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pahc-20230616_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pahc-20230616_pre.xml EX-101.PRE 22587
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2318884d1_8k_htm.xml XML 3669
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

IRS No.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36410 | Film No.: 231021439
SIC: 2834 Pharmaceutical Preparations